Lumisys to enter Internet businessX-ray film digitizer and computed radiography developer Lumisys has broadened the focus of its company with the launch of AuntMinnie.com, a new Internet business unit. Lumisys plans to create a comprehensive
X-ray film digitizer and computed radiography developer Lumisys has broadened the focus of its company with the launch of AuntMinnie.com, a new Internet business unit. Lumisys plans to create a comprehensive portal Internet site for radiologists and professionals in the medical imaging industry. Launch is expected in October.
In other news, the Sunnyvale, CA-based firm reported a 22% increase in revenue for its second quarter (end-June). Revenues were $5 million, compared with $4.1 million a year ago.
The company posted a net loss for the period of $3.8 million, which included a one-time, non-cash charge of $4 million related to the firms sale of its former Imagraph subsidiary to Foresight Imaging (PNN 7/99). Lumisys had net income of $62,000 in 1998.
Lumisys credited sales of its ACR-2000 DesktopCR system for the increase in revenues. The vendor shipped 54 units during the second quarter and 129 during the first half of the year.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.